Review article
Click the PDF button.
Baillargeon J et al., The association of body mass index and prostate-specific antigen in a population-based study, Cancer, 2005
10.1002/cncr.2085615668913Hamilton RJ et al., The influence of statin medications on prostate-specific antigen levels, J Natl Cancer Inst, 2008
10.1093/jnci/djn36218957682FDA Approved Drug Products: PROSCAR (finasteride) tablets (website: http://extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s047lbl.pdf)
Smith AB et al., Finasteride in the treatment of patients with benign prostatic hyperplasia: a review, Ther Clin Risk Manag, 2009
Kaplan SA et al., PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: Preliminary study, Urology, 2002
10.1016/S0090-4295(02)01760-012350485Andriole GL et al., Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride, J Urol, 2006
10.1016/S0022-5347(05)00984-516600723Marks LS et al., The interpretation of serum prostate specific antigen in men receiving 5a-reductase inhibitors: A review and clinical recommendations, J Urol, 2006
10.1016/j.juro.2006.04.02416890642- Publisher :The Association of Korean Urologists
- Publisher(Ko) :대한비뇨의학과의사회
- Journal Title :비뇨의학 Urology Digest
- Volume : 5
- No :2
- Pages :49-52